Published in J Clin Invest on September 01, 1981
Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix. J Cell Biol (1984) 1.23
Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin. J Clin Invest (1988) 1.04
Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma. Arch Dermatol Res (1989) 0.93
Immunoregulation of lung fibroblast growth: alteration in asbestos-induced pulmonary fibrosis. Clin Exp Immunol (1986) 0.79
In vitro suppression of fibroblast growth inhibitory lymphokine production by asbestos. Clin Exp Immunol (1983) 0.78
Immune-induced vascular connective tissue alterations in rabbits chronically immunized with bovine serum albumin: morphological and morphometric studies on normal and injured thoracic aorta. Br J Exp Pathol (1986) 0.75
Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med (1954) 68.67
Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem (1975) 4.25
Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Proc Natl Acad Sci U S A (1968) 1.95
Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes. J Immunol (1970) 1.81
Lymphocyte in vitro cytotoxicity: correlation of derepression with release of lymphotoxin from human lymphocytes. J Immunol (1969) 1.53
Fibroblasts as an experimental tool in metabolic and hormone studies. II. Effects of insulin and nonsuppressible insulin-like activity (NSILA-S) on fibroblasts in culture. Eur J Clin Invest (1973) 1.29
Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctes. J Immunol (1975) 1.24
The effect of cell density on net rates of glycosaminoglycan synthesis and secretion by cultured rat fibroblasts. J Biol Chem (1980) 1.24
Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor. Arthritis Rheum (1977) 1.15
Pathophysiology of rheumatoid arthritis. Fed Proc (1973) 1.10
Synovial cell activation induced by a polypeptide mediator. Ann N Y Acad Sci (1975) 1.07
Leukocyte-connective tissue cell interaction. II. The specificity, duration, and mechanism of interaction effects. Arthritis Rheum (1969) 1.02
Cytotoxic activity of lymphocytes. VI. Heterogeneity of cytotoxins in supernatants of mitogen-activated lymphocytes. J Immunol (1976) 1.00
The growth kinetics of synovial fibroblastic cells from inflammatory and noninflammatory arthropathies. Arthritis Rheum (1978) 0.97
Direct observations on the effect of "proliferation inhibitory factor" on the clonal growth of target cells. J Immunol (1971) 0.87
A serum factor capable of stimulating hyaluronic acid synthesis in cultured rat fibroblasts. J Cell Physiol (1977) 0.87
The production of proliferation inhibitory factor (pif) by mouse spleen cells in vitro. J Immunol (1974) 0.84
Target cell lysis mediated by soluble cytotoxin released from stimulated lymphocytes. Nat New Biol (1971) 0.83
Role of pH in fibroblast proliferation. J Cell Physiol (1974) 0.81
Glycosaminoglycan synthesis and glucose uptake by rheumatoid and nonrheumatoid fibroblastic cells in culture. The effect of nutritional factors. Arthritis Rheum (1979) 0.81
Cytotoxic activity of lymphocytes. VII. cellular origin of alpha-lymphotoxin. J Immunol (1978) 0.81
Identification of multiple cytolytic components associated with the beta-LT class of lymphotoxins released by mitogen-activity human lymphocytes in vitro. J Immunol (1976) 0.80
Quantitation and interaction of glycosaminoglycans with Alcian blue in dimethyl sulfoxide solutions. Anal Biochem (1979) 0.78
Regulatory substances produced by lymphocytes. III. Evidence that lymphotoxin and proliferation inhibitory factor are identical and different from the inhibitor of DNA synthesis. J Immunol (1976) 0.78
Rates of glycosaminoglycan synthesis and rates of incorporation of radioactive precursors into newly synthesized glycosaminoglycan by confluent rat muscle fibroblasts. J Biol Chem (1980) 0.78
Characterization of glycosaminoglycan-Alcian blue complexes by elution from cellulose acetate utilizing different MgCl2 concentrations. Anal Biochem (1980) 0.78
Possible limitation of growth in human fibroblast cultures by diffusion. J Cell Physiol (1975) 0.77
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med (2001) 5.29
Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (2005) 3.00
Intravenous cyclosporine kinetics in renal failure. Clin Pharmacol Ther (1983) 1.73
White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. Neurology (2010) 1.55
Delivering a selective neonatal BCG vaccination programme in a multi-ethnic community: an audit of the neonatal BCG immunisation programme in Birmingham and Solihull. Commun Dis Public Health (2004) 1.49
Stability of attendance in general practice. Fam Pract (1994) 1.45
Hepatitis B vaccination and GPs. Practitioner (1989) 1.45
Progressive rheumatoid arthritis: how far should we go with medical therapy? Can Med Assoc J (1980) 1.40
Rating the appropriateness of coronary angiography, coronary angioplasty and coronary artery bypass grafting: the ACRE study. Appropriateness of Coronary Revascularisation study. J Public Health Med (1999) 1.36
Percutaneous dilatational tracheostomy: haemorrhagic complications and the vascular anatomy of the anterior neck. A review based on 497 cases. Int J Oral Maxillofac Surg (2000) 1.35
Segregation and early dispersal of neural crest cells in the embryonic zebrafish. Dev Dyn (1992) 1.35
Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods. Arthritis Rheum (1979) 1.32
Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. J Rheumatol (1991) 1.28
Which depressed patients respond to cognitive-behavioral treatment? J Am Acad Child Adolesc Psychiatry (1998) 1.25
The effect of cell density on net rates of glycosaminoglycan synthesis and secretion by cultured rat fibroblasts. J Biol Chem (1980) 1.24
Efficacy of urgent thoracotomy for trauma in patients attended by a helicopter emergency medical service. J R Coll Surg Edinb (1994) 1.22
Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (2001) 1.21
Comparison of two methods of preventing central nervous system leukemia. Blood (1973) 1.19
Optic fibre bundle contact imaging probe employing a laser scanning confocal microscope. J Microsc (2002) 1.15
Regulation of human platelet adenylate cyclase by epinephrine, prostaglandin E1, and guanine nucleotides. Evidence for separate guanine nucleotide sites mediating stimulation and inhibition. J Biol Chem (1979) 1.13
Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann N Y Acad Sci (1999) 1.12
A pilot study of 'fast track' antenatal screening for haemoglobinopathies. J Med Screen (2003) 1.12
Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trial. N Engl J Med (1983) 1.11
The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis. Arthritis Rheum (1980) 1.11
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil (2007) 1.10
PCR and the notification of meningococcal disease. Commun Dis Public Health (2002) 1.07
Childhood acute lymphocytic leukemia: study VIII. Cancer (1978) 1.07
Monitoring the health-related labelling of foods and non-alcoholic beverages in retail settings. Obes Rev (2013) 1.07
Guidance of oligodendrocytes and their progenitors by substratum topography. J Cell Sci (1995) 1.06
How much do medical students know about infection control? J Hosp Infect (2006) 1.04
Oxidative metabolism of polycyclic aromatic hydrocarbons to ultimate carcinogens. Drug Metab Rev (1982) 1.03
An orchestrated gene expression component of neuronal programmed cell death revealed by cDNA array analysis. Proc Natl Acad Sci U S A (2001) 1.02
Sexually inappropriate behaviour in demented elderly people. Postgrad Med J (2005) 1.02
beta -Amyloid peptide-induced apoptosis regulated by a novel protein containing a g protein activation module. J Biol Chem (2001) 1.01
In vitro studies on the heterogeneity of equine antibodies to human lymphoid tissue. Immunochemistry (1969) 1.00
A genetic study of ADHD and activity level in infancy. Genes Brain Behav (2009) 0.99
Recurrent symptoms after ventricular pacing in unexplained syncope. Pacing Clin Electrophysiol (1990) 0.98
Regulation of Tiam1 nucleotide exchange activity by pleckstrin domain binding ligands. J Biol Chem (2000) 0.98
Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2. J Virol (2000) 0.97
The growth kinetics of synovial fibroblastic cells from inflammatory and noninflammatory arthropathies. Arthritis Rheum (1978) 0.97
Antitussive properties of inhaled bronchodilators on induced cough. Chest (1988) 0.96
Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6. J Clin Pathol (2001) 0.96
Contagious bovine pleuropneumonia. The costs of control in Central/southern Africa. Ann N Y Acad Sci (1998) 0.95
Long-term neurological implications of somnolence syndrome in children with acute lymphocytic leukemia. Ann Neurol (1980) 0.95
An analysis of in vivo cell migration during teleost fin morphogenesis. J Cell Sci (1984) 0.95
The orf virus OV20.0L gene product is involved in interferon resistance and inhibits an interferon-inducible, double-stranded RNA-dependent kinase. Immunology (1998) 0.95
Antibiotics carried in general practitioners' emergency bags. May not be used when required. BMJ (1995) 0.94
Polymyositis in chronic graft vs host disease. A case report. Arch Neurol (1982) 0.94
Size and shape of the corpus callosum in adult Niemann-Pick type C reflects state and trait illness variables. AJNR Am J Neuroradiol (2011) 0.93
Pancreatitis arthritis with periarticular fat necrosis. J Rheumatol (1993) 0.93
Glial lineages and myelination in the central nervous system. J Anat (1997) 0.92
RNA synthesis in germinating embryonic axes of soybean and wheat. Plant Physiol (1980) 0.92
Transient global amnesia and cortical blindness after vertebral angiography: further evidence for the role of arterial spasm. AJNR Am J Neuroradiol (1995) 0.92
p47phox-deficient immune microenvironment signals dysregulate naive T-cell apoptosis. Cell Death Differ (2008) 0.91
Aortic incompetence in HLA B27-positive juvenile arthritis. Ann Rheum Dis (1980) 0.91
Sexual development of malaria parasites is inhibited in vitro by the neem extract azadirachtin, and its semi-synthetic analogues. FEMS Microbiol Lett (1994) 0.91
Prevalence and nature of anaemia in a prospective, population-based sample of people with diabetes: Teesside anaemia in diabetes (TAD) study. Diabet Med (2010) 0.91
The effect of glucosamine on glucose metabolism in humans: a systematic review of the literature. Osteoarthritis Cartilage (2011) 0.90
Remission-inducing drugs in rheumatoid arthritis. Can Med Assoc J (1980) 0.90
Evidence for a slowing in trimethoprim resistance during 1981--a comparison with earlier years. J Antimicrob Chemother (1983) 0.89
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. Br J Pharmacol (2012) 0.89
The development and distribution of antilymphocytic and other antibodies in horses immunized with human lymphoid antigens. Transplantation (1970) 0.88
Early pectoral fin development and morphogenesis of the apical ectodermal ridge in the killifish, Aphyosemion scheeli. Anat Rec (1982) 0.88
RADARx: Recognizing, Assessing, and Documenting Adverse Rx events. Proc AMIA Symp (2000) 0.86
Intra-articular steroid injections: a benefit or a hazard? Can Med Assoc J (1980) 0.86
Developmental regulation of neurogenesis in the pluripotent human embryonal carcinoma cell line NTERA-2. Eur J Neurosci (2000) 0.86
Nonsteroidal anti-inflammatory agents in the primary treatment of rheumatoid arthritis. Can Med Assoc J (1979) 0.86
A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers. J Psychopharmacol (1999) 0.86
The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections. Br J Clin Pharmacol (1994) 0.86
Noonan syndrome: coagulation and clinical aspects. Acta Paediatr (1996) 0.84
Emergency thoracotomy for thoracic trauma in the accident and emergency department: indications and outcome. Ann R Coll Surg Engl (1996) 0.84
Interobserver variation in the chest radiograph component of the lung injury score. Anaesthesia (1995) 0.84
Progress on obesity prevention over 20 years in Australia and New Zealand. Obes Rev (2013) 0.84
Radiographic and hemodynamic evaluation of cardiomyopathy and thromboembolism in the cat. J Am Vet Med Assoc (1974) 0.84
Glucosamine therapy for osteoarthritis. J Rheumatol (1999) 0.84
Effect of zinc, copper and glucocorticoids on metallothionein levels of cultured neurons and astrocytes from rat brain. Chem Biol Interact (1994) 0.83
Nephropathic cystinosis with bone marrow involvement. Br J Haematol (2007) 0.83
Comparison of the combined cortical thickness of the second metacarpal with Sharp's method for scoring hand microradiographs in rheumatoid arthritis. J Rheumatol (1998) 0.83
An in vivo analysis of the effectiveness of the osteoarthritic knee brace during heel-strike of gait. J Arthroplasty (1999) 0.83
Risk of developing tuberculosis from a school contact: retrospective cohort study, United Kingdom, 2009. Euro Surveill (2010) 0.83
Antitumor efficacy of AG3340 associated with maintenance of minimum effective plasma concentrations and not total daily dose, exposure or peak plasma concentrations. Invest New Drugs (1999) 0.83
Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol (1991) 0.83
Visuospatial ability and memory are associated with falls risk in older people: a population-based study. Dement Geriatr Cogn Disord (2009) 0.82
Failure to stimulate antibodies in man after 7 days' high-dose treatment with rifampicin. Lancet (1981) 0.82
Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UK. Leuk Lymphoma (1997) 0.82
Differences in hepatitis B infection rate between ethnic groups in antenatal women in Birmingham, United Kingdom, May 2004 to December 2008. Euro Surveill (2012) 0.82
Role of pH in fibroblast proliferation. J Cell Physiol (1974) 0.81
Inhibitory effects of sodium and other monovalent cations on human platelet adenylate cyclase. J Biol Chem (1981) 0.81
The prevention of corticosteroid-induced bone loss with intermittent cyclical etidronate. Scand J Rheumatol (1999) 0.81
Uptake of influenza vaccination in rheumatology patients: reply. Rheumatology (Oxford) (2005) 0.81
Origin and immunological hyporeactivity of canine alveolar lymphocytes. Immunology (1985) 0.81
Glycosaminoglycan synthesis and glucose uptake by rheumatoid and nonrheumatoid fibroblastic cells in culture. The effect of nutritional factors. Arthritis Rheum (1979) 0.81
Visual disturbances and seizures associated with pregnancy: a diagnostic dilemma and the role of radiological techniques as an aid to diagnosis. Int J Obstet Anesth (1999) 0.81
Successful pregnancy following two uterine artery embolisation procedures for arteriovenous malformation. J Obstet Gynaecol (2004) 0.80
Antisera to the variable region of ras oncogene proteins, and specific detection of H-ras expression in an experimental model of chemical carcinogenesis. Oncogene (1987) 0.80
Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia. Cancer (1980) 0.80